Sovaldi (Sofosbuvir) marked the true beginning of a new era in hepatitis C treatment. With cure rates exceeding 90%, Sovaldi gave millions of patients hope for recovery.
What is Sovaldi?
Sovaldi (Sofosbuvir) works by inhibiting the NS5B polymerase enzyme essential for hepatitis C virus replication. When combined with other drugs such as Ribavirin or Ledipasvir, Sovaldi achieves outstanding treatment outcomes.
Indications
-
Chronic hepatitis C infection across multiple genotypes.
Administration
Sovaldi is taken orally as a once-daily tablet. The treatment duration varies between 12 and 24 weeks depending on the patient’s condition and viral genotype.
Common Side Effects
-
Fatigue and general tiredness.
-
Headache of varying intensity.
-
Nausea or mild gastrointestinal issues.
-
Occasionally loss of appetite or sleep disturbances.
Availability and Price in Egypt
Sovaldi in Egypt is widely available at much lower prices thanks to generic alternatives. It played a major role in the national program that successfully reduced hepatitis C prevalence in Egypt.
Conclusion
Sovaldi (Sofosbuvir) remains a revolutionary antiviral drug that transformed hepatitis C treatment worldwide. In Egypt, it became a symbol of the country’s success in combating this disease.
Contact the Macrocare team about starting treatment and booking a medical consultation.